A
Azza Karrar
Researcher at Inova Health System
Publications - 5
Citations - 37
Azza Karrar is an academic researcher from Inova Health System. The author has contributed to research in topics: Fatty liver & Steatohepatitis. The author has an hindex of 4, co-authored 5 publications receiving 30 citations.
Papers
More filters
Journal ArticleDOI
Fatigue in chronic liver disease: exploring the role of the autonomic nervous system.
TL;DR: Some general aspects of fatigue, its taxonomy, and the findings reported by Dyson et al. are proposed, which contribute to the understanding of fatigue in chronic liver disease by demonstrating an association between sympathetic over-activity, increased cardiac output and primary sclerosing cholangitis.
Journal ArticleDOI
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV)
Pegah Golabi,Elzafir Elsheikh,Azza Karrar,James M. Estep,Issah Younossi,Maria Stepanova,Lynn H. Gerber,Zobair M. Younossi +7 more
TL;DR: The neurotransmitters and cytokines were found to be independent predictors of MEH scores in multiple regression analysis andCytokine and neurotransmitter changes are associated with mental and emotional health.
Journal ArticleDOI
Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease.
Azza Karrar,Siddharth Hariharan,Yousef Fazel,Ali Moosvi,Mohamad Houry,Zahra Younoszai,Thomas Jeffers,Li Zheng,Otgonsuren Munkhzul,Sharon L. Hunt,Fanny Monge,Zachary Goodman,Zobair M. Younossi +12 more
TL;DR: The findings indicate that HLA class I and II gene polymorphism may be associated with susceptibility to NASH, fibrosis and other pathologic features and may be involved in the pathogenesis of NAFLD.
Journal ArticleDOI
Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease
Azza Karrar,Maria Stepanova,Lakshmi Alaparthi,Sneha Lingam,Zahra Younoszai,Li Zheng,Khatera S. Malik,Elena Younossi,Fanny Monge,Sharon L. Hunt,Zachary Goodman,Zachary Goodman,Zobair M. Younossi,Zobair M. Younossi +13 more
TL;DR: The aim was to assess the role of disease and cell‐specific antibodies, namely anti‐adipocyte antibodies (anti‐AdAb) in patients with NAFLD and non‐alcoholic steatohepatitis (NASH).
Journal ArticleDOI
Serum Amyloid A Is Strongly Associated With Hyperlipidemia in Patients With Non-alcoholic Fatty Liver Disease (NAFLD): 2090
Azza Karrar,Dinan Abdelatif,Irfan Ali,Mohamad Houry,Siddharth Hariharan,Khatera Salam,Sara Kim,Sreya Addanki,Zahra Younoszai,Munkhzul Otgonsuren,Zachary Goodman,Zobair M. Younossi +11 more
TL;DR: HCC DNA markers can be detected in urine of patients with HCC by short-amplicon, PCR-based assays and in combination with serum AFP, three biomarker urine DNA testing detected at least 30% more HCC in an open-labeled study compared to serum AFP alone.